Back

microRNA-21 as a prognostic biomarker of sacubitril/valsartan treatment response in heart failure with reduced ejection fraction

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic heart failure – Diagnostic methods Biomarkers ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Maria Marketou

University Hospital of Heraklion, Heraklion (Greece)

13 More presentations in this session

Presentation thumbnail
Doctor A. Santoso (Jakarta, ID)
Presentation thumbnail
Doctor M. Spinarova (Brno, CZ)
Abstract Slides
Presentation thumbnail
Professor C. Pemberton (Christchurch, NZ)
Abstract
Presentation thumbnail
Associate Professor S. Joho (Toyama, JP)
Abstract
Presentation thumbnail
Assistant Professor P. Jirak (Salzburg, AT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic heart failure – Diagnostic methods

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing
29 June 2021
thumbnail
Congress Presentation
Treatment trajectory of Sacubitril/Valsartan initiation among >50,000 older adults with heart failure with reduced ejection fraction in the United States
21 May 2023
thumbnail
ESC Journals
Right ventricular strain as prognostic marker in patients with heart failure receiving sacubitril/valsartan: a sub-analysis of DISCOVER-ARNI, a multicenter Italian study
29 January 2025
thumbnail
Congress Presentation
Systemic H-FABP, hs-cTnT, hs-CRP and Monocyte-to-Lymphocyte ratio were significantly reduced by sacubitril/valsartan in doxorubicin-treated preclinical models through NLRP3-mTOR-AKT pathways
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources